Paddy Horner: 2/52 window is biologically implausible given sensitivity of NAAT assays, and denying testing risks reducing access to care
The ‘for’ debate conclusions -Paddy Horner #vBASHH21
@AchyutaNori: not all chlamydia tests are created equal; even though RNA typically degrades, it can sometimes persist (up to centuries!) Hard to tell if your infecting organism is alive/viable or not.
#vBASHH21 Goals are to avoid non-significant unviable positive CT results and overtreatment; chat contributors suggest testing at presentation *and* at 2 weeks via home kit. What do you do in your centre? Let us know
Time for the post-debate vote: have you changed your mind?
Now 42% for, 58% against! Very slight difference. Congrats to both presenters for very interesting arguments.
Questions: do these arguments change for, eg. extragenital sites or special populations like MSM or pregnant people? Answer: we don't yet know.
Do asympto contacts need empiric therapy? Risk of complications is low, perhaps we should reconsider current approach.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Time for the keynote speech from #PaddyHorner: Is there a hidden burden of disease as a result of epigenetic epithelial-to-mesenchymal transition following chlamydial genital infection? #vBASHH21
Kicking off the short oral abstract session: #MiriamRingshall discussing chemsex, Doxy STI PrEP and influence of the pandemic on sex behaviour in Brighton MSM
High rates of drug use inc. chems, STIPrEP, multiple sexual partners. How does this compare to your service users? And how do you support? Apps may be helpful #vBASHH21
Next: Tia Hunjan describing possible pathophysiology of hypoactive sexual desire disorder, which is commoner in young women with an estimated prevalence of 10%